Anthropic's Investors Want a $2 Trillion IPO. The Last Record-Setting IPO Has Made Its Buyers Nothing in Two Months.

Anthropic backers reportedly want an October IPO at a $2 trillion valuation or higher, potentially overtaking SpaceX’s June record—SpaceX priced at $135/share (about $1.77T) and shares have swung 67% to $225.64 and down 22% to $104.83. The article cites Anthropic’s investors projecting $100B–$120B of annualized revenue by year-end and notes Anthropic’s executives have not fixed a valuation. Using SpaceX as a case study, the post-IPO trading suggests investors may be underwriting growth “upfront,” leaving limited near-term upside if results merely match expectations.

Analysis

The real market signal is not the company being priced, but the clearing price for late-stage AI risk. When private rounds reset this aggressively, public investors should expect a short-lived sympathy rally in the entire AI basket, followed by multiple compression for any name whose path to monetization is still narrative-driven rather than cash-flow-driven. That dynamic tends to favor the obvious infrastructure beneficiaries over application-layer beta: capital markets will keep rewarding the companies that sell picks-and-shovels into the boom, while punishing those that need a perfect growth trajectory to justify their own valuations.

For listed names, the second-order effect is that AI capex expectations may stay elevated for another 1-3 quarters, which is supportive for NVDA on the demand side and for adjacent compute suppliers, but only if customers can continue to raise money at these marks. If the IPO window opens and then trades poorly after lockup, it becomes a warning shot for the whole private AI complex: funding becomes less elastic, secondary sales get discounted, and public comps can de-rate even if operating metrics remain strong. The key falsifier is not the initial pricing headline; it is whether post-listing performance sustains, because weak aftermarket action would imply the marginal buyer is already saturated.

Contrarian view: the market is probably underestimating how much of this is a financing event rather than a valuation event. A premium private round at a headline number does not create public-market liquidity, and if the float is tight, first-day prints can look great while actual price discovery remains fragile for months. The cleaner tell will be whether broad AI leaders like NVDA can hold relative strength after the IPO hype fades; if they cannot, it suggests investors are starting to separate durable compute demand from speculative model-company optionality.

Key Decisions for Investors

• Keep NVDA as the highest-quality public expression of AI financing momentum, but treat it as a tactical long only on post-IPO weakness; thesis holds over 1-3 months if AI capex commentary stays strong, invalidated if demand guidance or gross margin turns down.
• Fade the most expensive unprofitable AI-adjacent names on any IPO-rally spillover using a basket short versus NVDA strength; the trade works if public-market appetite rotates from 'growth at any price' to 'cash-flow visibility' over the next 1-2 quarters.
• Set an alert for the first public pricing and first 2-4 weeks of trading in the new AI listing; if the stock trades below deal price after a brief squeeze, use that as a signal to reduce exposure to private-market AI proxies and high-multiple software.
• No direct trade on SPCX from this note: the better signal is not the IPO itself but whether the aftermarket can absorb supply without repeated drawdowns; if it cannot, expect broader de-rating pressure across AI/IPO sentiment names.
• For a relative-value expression, consider long NVDA / short a basket of profitless software or speculative AI software proxies on strength; risk/reward improves if the IPO window drives a near-term valuation premium that later mean-reverts.